Education
About Us
Working with TipRanks
Follow Us
Mp Materials Corp (MP)
:MP
MP Analyst Ratings
Strong Buy
7 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MP Stock 12 Month Forecast
Average Price Target
$29.14
▼(-19.03%Downside)
| Highest Price Target$38.00 | Average Price Target$29.14 | Lowest Price Target$18.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$36
Hold
0.03%
Upside
Reiterated
06/17/25
The financial performance of MP Materials is the most significant factor contributing to its overall score, as the company faces revenue and profitability challenges. Technical analysis shows strong momentum, but valuation metrics are weak due to negative earnings. The earnings call highlights both strategic advances and operational challenges, suggesting potential long-term growth amid short-term difficulties.
Morgan Stanley
$34
Buy
-5.53%
Downside
Upgraded
06/20/25
Robert W. Baird
$30→$38
Buy
5.58%
Upside
Reiterated
06/17/25
Bank of America Securities
$30
Buy
-16.64%
Downside
Reiterated
06/11/25
D.A. Davidson
―
Buy
―
Reiterated
05/27/25
Canaccord Genuity
$27
Buy
-24.98%
Downside
Reiterated
05/14/25
TD Cowen
$25
Buy
-30.54%
Downside
Reiterated
05/08/25
Jefferies
$32
Buy
-11.09%
Downside
Reiterated
05/08/25
BMO Capital
$22→$29
Hold
-19.42%
Downside
Reiterated
03/19/25
Leerink Partners
$28
Buy
-22.20%
Downside
Initiated
02/24/25
MP Materials (MP) Receives a New Rating from Leerink PartnersWe are initiating coverage of Beta Bionics (BBNX) with an Outperform rating and a $28 price target. In our view, BBNX is building a foundational platform and has put all the right pieces in place to become the next key player in diabetes technology. BBNX is commercializing its disruptive iLet insulin pump system that offers clear product differentiation through its simple, easy-to-use algorithm. We believe BBNX can achieve continued commercial momentum by leveraging iLet's innovative algorithm, superior CGM integration capabilities, and favorable pharmacy access relative to certain peers.
Benchmark Co.
$30
Buy
-16.64%
Downside
Reiterated
01/30/25
Deutsche Bank
$13.5→$12.5
Hold
-65.27%
Downside
Reiterated
08/06/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$36
Hold
0.03%
Upside
Reiterated
06/17/25
The financial performance of MP Materials is the most significant factor contributing to its overall score, as the company faces revenue and profitability challenges. Technical analysis shows strong momentum, but valuation metrics are weak due to negative earnings. The earnings call highlights both strategic advances and operational challenges, suggesting potential long-term growth amid short-term difficulties.
Morgan Stanley
$34
Buy
-5.53%
Downside
Upgraded
06/20/25
Robert W. Baird
$30→$38
Buy
5.58%
Upside
Reiterated
06/17/25
Bank of America Securities
$30
Buy
-16.64%
Downside
Reiterated
06/11/25
D.A. Davidson
―
Buy
―
Reiterated
05/27/25
Canaccord Genuity
$27
Buy
-24.98%
Downside
Reiterated
05/14/25
TD Cowen
$25
Buy
-30.54%
Downside
Reiterated
05/08/25
Jefferies
$32
Buy
-11.09%
Downside
Reiterated
05/08/25
BMO Capital
$22→$29
Hold
-19.42%
Downside
Reiterated
03/19/25
Leerink Partners
$28
Buy
-22.20%
Downside
Initiated
02/24/25
MP Materials (MP) Receives a New Rating from Leerink PartnersWe are initiating coverage of Beta Bionics (BBNX) with an Outperform rating and a $28 price target. In our view, BBNX is building a foundational platform and has put all the right pieces in place to become the next key player in diabetes technology. BBNX is commercializing its disruptive iLet insulin pump system that offers clear product differentiation through its simple, easy-to-use algorithm. We believe BBNX can achieve continued commercial momentum by leveraging iLet's innovative algorithm, superior CGM integration capabilities, and favorable pharmacy access relative to certain peers.
Benchmark Co.
$30
Buy
-16.64%
Downside
Reiterated
01/30/25
Deutsche Bank
$13.5→$12.5
Hold
-65.27%
Downside
Reiterated
08/06/24
Best Analysts Covering MP Materials
1 Month
xxx
Success Rate
13/17 ratings generated profit
Average Return
+7.84%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 76.47% of your transactions generating a profit, with an average return of +7.84% per trade.
3 Months
xxx
Success Rate
12/18 ratings generated profit
Average Return
+7.61%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +7.61% per trade.
1 Year
Success Rate
12/17 ratings generated profit
Average Return
+39.20%
reiterated a buy rating 2 months ago
Copying George Gianarikas's trades and holding each position for 1 Year would result in 70.59% of your transactions generating a profit, with an average return of +39.20% per trade.
2 Years
xxx
Success Rate
14/18 ratings generated profit
Average Return
+52.60%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 77.78% of your transactions generating a profit, with an average return of +52.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MP Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
0
0
0
1
1
Buy
14
15
12
11
14
Hold
6
6
8
10
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
21
20
22
24
Each month's total comprises the sum of three months' worth of ratings.
MP Financial Forecast
MP Stock Forecast FAQ
What is MP’s average 12-month price target, according to analysts?
Based on analyst ratings, Mp Materials Corp’s 12-month average price target is 29.14.
What is MP’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MP, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MP a Buy, Sell or Hold?
Mp Materials Corp has a consensus rating of Strong Buy which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
What is Mp Materials Corp’s price target?
The average price target for Mp Materials Corp is 29.14. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $38.00 ,the lowest forecast is $18.00. The average price target represents -19.03% Decrease from the current price of $35.99.
The highest analyst price target is $38.00 ,the lowest forecast is $18.00. The average price target represents -19.03% Decrease from the current price of $35.99.
What do analysts say about Mp Materials Corp?
Mp Materials Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of MP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.